Declaration on honour on exclusion criteria and selection criteria to be completed and returned by email together with the request to participate. UCA 24/001 Annex I Declaration on honour on exclusion ...
A climate-resilient development pathway which enables Fiji to anticipate, reduce, and manage environmental and climate risks caused by climate variability and change to support a vibrant society and ...
FOG-001 is under clinical development by Fog Pharmaceuticals and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase II drugs for Metastatic Colorectal Cancer have a ...
GXV-001 is under clinical development by GEXVal and currently in Phase I for Rett Syndrome. According to GlobalData, Phase I drugs for Rett Syndrome does not have sufficient historical data to build ...
An illustration of a magnifying glass. An illustration of a magnifying glass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results